Vitamin E supplementation in hyperlipidaemic patients: Effect of increasing doses on in vitro and in vivo low-density lipoprotein oxidation

European Journal of Clinical Investigation

Volumn 29, Issue 12, 1999, Pages 1027-1034

  Wen, Y ^a   Killalea, S ^a   Norris, L A ^a   Cooke, T ^b   Feely, J ^a,c  

^a ST JAMES S HOSPITAL   (Ireland)

^b DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^c UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

Author keywords

Antioxidant supplementation; Atherosclerosis; Free radical; Low density lipoprotein oxidation; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; COPPER; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE;

ADULT; ANTIBODY TITER; ARTICLE; ATHEROSCLEROSIS; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HALF LIFE TIME; HUMAN; HYPERLIPIDEMIA; MALE; OXIDATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VITAMIN SUPPLEMENTATION;

ANTIOXIDANTS; ARTERIOSCLEROSIS; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FREE RADICALS; HUMANS; HYPERLIPIDEMIAS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXIDATION-REDUCTION; VITAMIN E;

EID: 0032705875     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00579.x     Document Type: Article

References (35)

1. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet, 1994;344:793-8.
2. Steinberg D. Oxidative modification of LDL and atherogenesis. Circulation, 1997;95:1062-71.
3. Gey KF, Moser UK, Jordan P, Stahelin HB, Eichholzer M, Ludin E. Increased risk of cardiovascular disease at suboptimal plasma concentrations of essential antioxidants: an epidemiological update with special attention to carotene and vitamin C. Am J Clin Nutr, 1993;57 (Suppl.):787S-797S.
4. Stampfer MJ, Hennekens CH, Mason JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and risk of coronary heart disease in women. N Engl J Med, 1993;328:1444-9.
5. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med, 1993;328:1450-6.
6. Hodis HN, Mack WJ, LaBree L et al. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA, 1995;273:1849-954.
7. Stephens NG, Parsons A, Schofield PT et al. Randomised controlled trial of vitamin E in patients with coronary disease. Cambridge Heart Antioxidant Study (CHAOS). Lancet, 1996;347:781-6.
8. Losonczy KG, Harris TB, Havlik RJ Vitamin E, vitamin C, (Suppl.) use and risk of all cause and coronary disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. Am J Clin Nutr, 1996;64:190-6.
9. Esterbauer H, Striegl G, Puhl H, Dieber-Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Commun, 1988;6:67-75.
10. Regnström J, Nilsson J, Tornvall P, Landou u C, Hamsten A. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet, 1992;339:1183-6.
11. NRC (National Research Council) Recommended Dietary Allowances. 10th Ed. Washington DC: Natl Acad Press; 1989.
12. Rapola JM, Virtamo J, Ripatti S et al. Randomised trial of α-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet, 1997;349:1715-20.
13. Tatzber F and Esterbauer H. Autoantibodies to oxidized low-density lipoprotein. In: Bellomo G, Finardi G, Maggi E, Rice-Evans C, editors. Free Radicals, Lipoprotein Oxidation and Atherosclerosis. London: Richelieu Press; 1995.p.245-259.
14. Lavy A, Brook GJ, Dankner G, Amotz AB, Aviram M. Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients. Metabolism, 1991;40:794-9.
15. Araujo FB, Barbosa DS, Hsin CY, Maranhao RC, Abdalla DS. Evaluation of oxidative stress in patients with hyperlipidemia. Atherosclerosis, 1995;117:61-71.
16. Chung BH, Segrest JP, Ray MJ. Single vertical spin gradient ultracentrifugation. Meth Enzymol, 1986;128:181-209.
17. Markwell MAK, Haas S, Tolbert NE, Bieber LL. Protein determination in membrane and lipoprotein samples: manual and automated procedures. Meth Enzymol, 1981;72:296-303.
18. Palinski W, Ylä-Herttuala S, Rosenfeld ME et al. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis, 1990;10:325-35.
19. Tengblad M, Vessby B. Low tocopherol serum levels in subjects with abdominal adiposity. J Intern Med, 1993;234:53-60.
20. Sierra C, Pastor MC, De Ramon M. Liquid chromatography determination of α-tocopherol in erythrocytes. Clinica Chimica Acta, 1992;208:119-26.
21. Gey KF, Brubacher GB, Stahelin HB. Plasma levels of antioxidants in relation to ischemic heart disease and cancer. Am J Clin Nutr, 1987;45:1368-77.
22. Friedewald WT, Levy RI, Frederickson DS. Estimation of the concentration of LDL cholesterol in plasma, without use of the centrifuge. Clin Chem, 1972;18:499-502.
23. Dieber-Rotheneder M, Puhl W, Waeg G, Striegl G, Esterbauer H. Effect of oral supplementation with D-α-tocopherol on the vitamin E content of human low-density lipoproteins and resistance to oxidation. J Lipid Res, 1991;32:1325-32.
24. Jialal I, Fuller CJ, Huet BA. The effect of α-tocopherol supplementation on LDL oxidation. Arterioscler Thromb Vasc Biol, 1995;15:190-8.
25. Princen HMG, van Duyvenvoorde W, Buytenhek R, van der Laarse van Poppel G, Leuven JAG et al. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler Thromb Vasc Biol, 1995;15:325-33.
26. Perani G, Martignoni A, Salvini M et al. LDL oxidation in primary hypercholesterolaemia. In: Bellomo G, Finardi G, Maggi E, Rice-Evans C, editors. Free Radicals, Lipoprotein Oxidation, Atherosclerosis. London: Richelieu Press; 1995.p.287-304.
27. Maggi E, Marchesi E, Covini D, Negro C, Perani G, Bellomo G. Protective effects of carvedilol, a vasodilating β-adrenoceptor blocker, against in vivo low density lipoprotein oxidation in essential hypertension. J Cardiovasc Pharmacol, 1996;27:532-8.
28. Uusitupa MI, Niskanen L, Luoma J et al. Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol, 1996;16:1236-42.
29. Fruebis J, Bird DA, Pattison J, Palinski W. Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants. J Lipid Res, 1997;38:2455-64.
30. Salonen JT, Ylä-Hertuala S, Yamamoto R et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet, 1992;339:883-7.
31. Wu R, Lefvert AK. Autoantibodies against oxidized low density lipoproteins (oxLDL): Characterization of antibody isotype, subclass, affinity and effect on the macrophage uptake of oxLDL. Clin Exp Immunol, 1995;102:174-80.
32. Deveraj S, Jialal I. The effects of alpha-tocopherol on critical cells in atherogenesis. Current Opinion Lipidol, 1998;9:11-5.
33. Akeson AL, Woods CW, Mosher LB, Thomas CE, Jackson RL. Inhibition of IL-1 beta expression in THP-1 cells by probucol and tocopherol. Atherosclerosis, 1991;86:261-70.
34. Deveraj S, Li D, Jialal I. The effects of alpha-tocopherol supplementation on monocyte function-decreased lipid oxidation, IL-1b secretion and monocyte adhesion to endothelium. J Clin Invest, 1996;98:756-63.
35. Meydani SN, Meydani M, Blumberg JB et al. Vitamin E supplementation and in vivo immune response in healthy elderly subjects. JAMA, 1997;277:1380-6.